|
Market Closed -
Nasdaq Stockholm
21:00:00 06/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 122.10 SEK | +1.24% |
|
+1.41% | +14.97% |
| 11-03 | BioGaia: Clinical study shows reduced infant colic after seven days | FW |
| 10-28 | Biogaia's Vice Chairman David Dangoor Sells Shares for SEK 19m | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BIOGAIA AB | Biopharmaceuticals | +1.24% | +1.41% | +14.97% | +25.30% | +13.06% | 1.25B |  | | |
- Stock Market
- Stocks
- BIOG B Stock
- Charts BioGaia AB
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
